A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis
NCT 06649695 Brief Summary This is a multicenter open-label, phase 2 study…
Read more arrow_forwardNCT 06649695 Brief Summary This is a multicenter open-label, phase 2 study…
Read more arrow_forwardNCT 05384626 Brief Summary Phase 1/2, dose escalation and expansion study designed…
Read more arrow_forwardInside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.